Home Supplements How We Rate Blog
Conjugated bile acids (ox-derived)

Ox Bile / Bile Salts

Research reviewed: 2025-2026

Ox Bile / Bile Salts (Conjugated bile acids (ox-derived)) is a dietary supplement with 11 published peer-reviewed studies involving 137 participants, researched for Fat Digestion & Malabsorption, Post-Cholecystectomy Support, Fat-Soluble Vitamin Absorption and 2 more areas.

11
Studies
137
Participants
1999–2026
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Fat Digestion & Malabsorption

Moderate
2 studies 2 of 2 positive 52 participants

Post-Cholecystectomy Support

Moderate
2 studies 2 of 2 positive 124 participants

Fat-Soluble Vitamin Absorption

Moderate
2 studies 2 of 2 positive 50 participants

Heart Health

Weak
4 studies 1 of 4 positive 90 participants

Cognitive Function

Moderate
1 study 0 of 1 positive 47 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

2/11
Randomised
1/11
Double-Blind
1/11
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2012)
40
Study 2 (1999)
12
Study 1 (2015)
28
Study 2 (2018)
96
Study 1 (2015)
18
Study 2 (2021)
32
Study 3 (2026)
0
Study 4 (2025)
0

Research Timeline

When the studies were published

1
1999
1
2012
2
2015
1
2018
1
2021
4
2025
1
2026

All Studies

Detailed breakdown of each trial. Click to expand.

Fat Digestion & Malabsorption

1

To evaluate ox bile supplementation on fat digestion in post-cholecystectomy patients.

2012 40 participants 8 weeks 500 mg ox bile with meals
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate ox bile supplementation on fat digestion in post-cholecystectomy patients.

Dose

500 mg ox bile with meals

Participants

40 patients post-cholecystectomy with fat malabsorption

Duration

8 weeks

Results

Ox bile significantly reduced fecal fat excretion and improved stool consistency. GI symptoms (bloating, diarrhea) were significantly reduced.

How They Measured It

Fecal fat excretion, stool frequency, GI symptom scores

Read full study
2

To assess bile acid supplementation for fat malabsorption in short bowel syndrome.

1999 12 participants 4 weeks Conjugated bile acids 300-600 mg with meals
Human Study Positive

Study Type

Open-label clinical study

Purpose

To assess bile acid supplementation for fat malabsorption in short bowel syndrome.

Dose

Conjugated bile acids 300-600 mg with meals

Participants

12 patients with short bowel syndrome

Duration

4 weeks

Results

Bile acid supplementation significantly improved CFA and reduced steatorrhea episodes. Some patients were able to reduce parenteral nutrition dependence.

How They Measured It

72-hour fecal fat collection, CFA, steatorrhea frequency

Read full study

Post-Cholecystectomy Support

1

To evaluate bile salt supplementation for post-cholecystectomy diarrhea and GI symptoms.

2015 28 participants 12 weeks 300 mg conjugated bile salts with each meal
Human Study Positive

Study Type

Prospective clinical trial

Purpose

To evaluate bile salt supplementation for post-cholecystectomy diarrhea and GI symptoms.

Dose

300 mg conjugated bile salts with each meal

Participants

28 patients with persistent post-cholecystectomy diarrhea

Duration

12 weeks

Results

Bile salt supplementation reduced stool frequency from mean 4.2 to 1.8/day and significantly improved stool consistency. 82% of patients reported symptom improvement.

How They Measured It

Stool frequency, Bristol Stool Scale, patient symptom questionnaire

Read full study
2

To evaluate clinical outcomes of bile acid supplementation in post-cholecystectomy patients.

2018 96 participants 6 months follow-up Various ox bile preparations
Human Study Mixed

Study Type

Retrospective cohort study

Purpose

To evaluate clinical outcomes of bile acid supplementation in post-cholecystectomy patients.

Dose

Various ox bile preparations

Participants

96 post-cholecystectomy patients

Duration

6 months follow-up

Results

Bile acid supplementation was associated with improved fat-soluble vitamin levels and reduced GI symptom-related healthcare visits.

How They Measured It

Symptom resolution, healthcare utilization, fat-soluble vitamin levels

Read full study

Fat-Soluble Vitamin Absorption

1

To evaluate bile acid supplementation on fat-soluble vitamin absorption.

2015 18 participants Single-dose crossover 500 mg ox bile with meals
Human Study Positive

Study Type

Crossover study

Purpose

To evaluate bile acid supplementation on fat-soluble vitamin absorption.

Dose

500 mg ox bile with meals

Participants

18 adults with bile acid deficiency

Duration

Single-dose crossover

Results

Bile acid supplementation significantly increased postprandial absorption of vitamins D and E. Vitamin A absorption showed trend towards improvement.

How They Measured It

Serum vitamin A, D, E, K levels after standard fat-containing meal

Read full study
2

To evaluate conjugated bile acid replacement on vitamin D status in cholestatic liver disease.

2021 32 participants 12 weeks 300 mg conjugated bile acids daily
Human Study RCT Positive

Study Type

Randomised controlled trial

Purpose

To evaluate conjugated bile acid replacement on vitamin D status in cholestatic liver disease.

Dose

300 mg conjugated bile acids daily

Participants

32 patients with cholestatic liver disease and vitamin D deficiency

Duration

12 weeks

Results

Bile acid replacement + vitamin D achieved significantly higher serum 25(OH)D levels than vitamin D supplementation alone.

How They Measured It

Serum 25(OH)D levels, PTH levels

Read full study

Heart Health

3

n - 3 polyunsaturated fatty acids mediate hyodeoxycholic acid-FXR signaling to ameliorate metabolic dysfunction-associated fatty liver disease.

2026 ? participants Not specified See study
Human Study Mixed

Study Type

RCT

Purpose

n - 3 polyunsaturated fatty acids mediate hyodeoxycholic acid-FXR signaling to ameliorate metabolic dysfunction-associated fatty liver disease.

Dose

See study

Participants

Not specified

Duration

Not specified

Results

demonstrated that HDCA acts as an intestinal farnesoid X receptor (FXR) antagonist that decreased intestinal and hepatic ceramide accumulation, thereby ameliorating the MAFLD phenotype.

How They Measured It

PubMed PMID: 41045973. J Nutr Biochem

Read full study
4

Limosilactobacillus reuteri CCFM1388 Enhances Exercise Endurance by Modulating Intestinal Bile Acid Metabolism and Cholesterol Absorption.

2025 ? participants Not specified See study
Human Study Positive

Study Type

RCT

Purpose

Limosilactobacillus reuteri CCFM1388 Enhances Exercise Endurance by Modulating Intestinal Bile Acid Metabolism and Cholesterol Absorption.

Dose

See study

Participants

Not specified

Duration

Not specified

Results

demonstrated that CCFM1388 significantly improved exercise endurance by modulating testosterone biosynthesis.

How They Measured It

PubMed PMID: 40937886. Mol Nutr Food Res

Read full study
5

Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.

2025 90 participants Not specified See study
Human Study Mixed

Study Type

RCT

Purpose

Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.

Dose

See study

Participants

90 participants

Duration

Not specified

Results

CONCLUSIONS: VE could promote health by lowering LDL-C, partly and indirectly by affecting gut bacteria with the ability to produce SCFAs or metabolize bile acids.

How They Measured It

PubMed PMID: 40087044. Nutr Metab Cardiovasc Dis

Read full study
6

The effects of ursodeoxycholic acid on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials.

2025 ? participants Not specified See study
Human Study Mixed

Study Type

Meta-Analysis

Purpose

The effects of ursodeoxycholic acid on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials.

Dose

See study

Participants

Not specified

Duration

Not specified

Results

CONCLUSION: This systematic review and meta-analysis suggest that UDCA supplementation may improve BMI and DBP, whereas it may increase SBP and have no effect on weight or inflammation.

How They Measured It

PubMed PMID: 39984850. BMC Cardiovasc Disord

Read full study

Cognitive Function

7

Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease.

2025 47 participants 16 weeks See study
Human Study Mixed

Study Type

RCT

Purpose

Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease.

Dose

See study

Participants

47 participants

Duration

16 weeks

Results

CONCLUSIONS: Bile acid metabolism in MS is linked to brain and retinal atrophy.

How They Measured It

PubMed PMID: 39447576. Med

Read full study

Frequently Asked Questions

Common questions about Ox Bile / Bile Salts research

What does the research say about Ox Bile / Bile Salts?

There are currently 11 peer-reviewed studies on Ox Bile / Bile Salts (Conjugated bile acids (ox-derived)), involving 137 total participants. Research covers Fat digestion, Bile acid support, Post-cholecystectomy support and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Ox Bile / Bile Salts?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (11 human studies), and reported outcomes.

What health goals has Ox Bile / Bile Salts been studied for?

Ox Bile / Bile Salts has been researched for: Fat digestion, Bile acid support, Post-cholecystectomy support, Fat-soluble vitamin absorption. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Ox Bile / Bile Salts based on human trials?

Yes, 11 out of 11 studies are human trials. Human trials carry more weight in our evidence scoring system.